Avricore Health (AVCRF) Cash from Investing Activities (2015 - 2025)
Avricore Health (AVCRF) reported Cash from Investing Activities of -$77501.4 for Q3 2025, up 45.21% year-over-year from -$53370.7 in Q3 2024, and down 21.75% quarter-over-quarter from -$63653.6 in Q2 2025.
Avricore Health (AVCRF) Cash from Investing Activities (2015 - 2025) Analysis & Trends
Avricore Health (AVCRF) has 8 years of Cash from Investing Activities data on file, last reported at -$77501.4 in Q3 2025.
- Cash from Investing Activities for Q3 2025 came in at -$77501.4, up 45.21% year-over-year; the trailing twelve-month figure through Sep 2025 was -$340023.1 (up 39.31% YoY), and the FY2025 annual result was -$81851.3, up 45.43% from the prior year.
- Cash from Investing Activities slipped to -$77501.4 in Q3 2025 per AVCRF's latest filing, from -$63653.6 in the prior quarter.
- Over five years, Cash from Investing Activities peaked at -$917.37 in Q1 2022 and troughed at -$467863.2 in Q3 2022.
- A 5-year average of -$127636.0 and a median of -$84329.7 in 2024 frame the typical range for Cash from Investing Activities.
- The sharpest annual moves came in 2022 and 2023: Cash from Investing Activities surged 72.99% in 2022, then slumped 18285.52% in 2023.
- A 5-year view of Cash from Investing Activities shows it stood at -$11381.2 in 2021, then slumped by 2743.0% to -$323567.3 in 2022, then rose by 18.06% to -$265140.1 in 2023, then soared by 46.65% to -$141461.0 in 2024, then soared by 45.21% to -$77501.4 in 2025.
- Business Quant data shows AVCRF's Cash from Investing Activities at -$77501.4 in Q3 2025, -$63653.6 in Q2 2025, and -$57407.1 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | 95.00 Mn |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | -8.96 Bn |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | -249.00 Mn |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | -33.54 Mn |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | -77.00 Mn |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | -196.00 Mn |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | -32.14 Mn |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | -366.00 Mn |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | -31.35 Mn |
| 10 | Avricore Health | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -77,501.44 |
| Sep 30, 2025 | -77,501.44 |
| Jun 30, 2025 | -63,653.60 |
| Jun 30, 2025 | -63,653.60 |
| Mar 31, 2025 | -57,407.10 |
| Mar 31, 2025 | -57,407.10 |
| Sep 30, 2024 | -141,460.98 |
| Sep 30, 2024 | -141,460.98 |
| Jun 30, 2024 | -91,157.87 |
| Jun 30, 2024 | -91,157.87 |
| Mar 31, 2024 | -62,477.03 |
| Mar 31, 2024 | -62,477.03 |
| Dec 31, 2023 | -265,140.15 |
| Dec 31, 2023 | -265,140.15 |
| Sep 30, 2023 | -199,467.78 |
| Sep 30, 2023 | -199,467.78 |
| Jun 30, 2023 | -141,796.61 |
| Jun 30, 2023 | -141,796.61 |
| Mar 31, 2023 | -168,663.35 |
| Mar 31, 2023 | -168,663.35 |